About International Conference on Malignant Lymphoma (ICML)
The International Conference on Malignant Lymphoma (ICML) is the leading international event devoted entirely to malignant lymphoma, driving progress in research and therapy worldwide. Held every two years at the Palazzo dei Congressi in Lugano, Switzerland, it is organised by the Foundation for the Institute of Oncology Research (IOR) in cooperation with the American Association for Cancer Research (AACR), the European School of Oncology Foundation (ESOF) and the European Society for Medical Oncology (ESMO). The 19th edition takes place from 15 to 19 June 2027.
Event Focus
Hodgkin Lymphoma | Diffuse Large B-Cell Lymphoma | Follicular Lymphoma | Mantle Cell Lymphoma | T-Cell Lymphomas | Chronic Lymphocytic Leukaemia | CAR T-Cell Therapy | Bispecific Antibodies | Lymphoma Biology & Genomics | Liquid Biopsy | Haematopathology | Clinical Trials
Event Highlights
Over five days, ICML combines general sessions with focused workshops, Meet the Professor sessions and challenging case discussions that tackle everyday clinical questions where best practice is not yet clear. The programme also features the ESMO-ICML Special Lecture, the Big Debate and a closing session with take-home messages, giving delegates a complete picture of where lymphoma research and treatment are heading.
Why Attend
ICML is the place where the international lymphoma community gathers to share important data and debate the future of treatment. Its focused, single-topic format makes it highly efficient for haematologists, oncologists, pathologists and researchers, as well as for companies active in lymphoma. Lugano's lakeside setting and compact city centre add a relaxed atmosphere to an intensive scientific week.
Cover photo: Francesco PIRANEO G., CC BY 3.0, via Wikimedia Commons
Organizer
Foundation for the Institute of Oncology Research (IOR)